Traynor Capital Management’s NervGen Pharma NGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$60.2K Hold
31,500
– – ﹤0.01% 319
2026
Q2
$64.9K Buy
31,500
+6,000
+24% +$18.6K ﹤0.01% 351
2026
Q1
$95.1K Buy
+25,500
New +$110K 0.01% 315

Other funds holding NGEN

Traynor Capital Management's NGEN Position: Q3 2026 in Review

Traynor Capital Management held its NervGen Pharma (NGEN) position steady in Q3 2026 at 31,500 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Traynor Capital Management first reported a position in NGEN in Q1 2026 and has held it in 3 quarters since. The position peaked at $95.1K in Q1 2026. 68 funds tracked by Wall St. Rank hold NGEN as of Q3 2026.

  • Traynor Capital Management held 31,500 shares of NervGen Pharma worth $60.2K as of Q3 2026.
  • Traynor Capital Management left its NervGen Pharma share count unchanged in Q3 2026.
  • NervGen Pharma made up ﹤0.01% of Traynor Capital Management's portfolio in Q3 2026, its #319 holding.
  • Traynor Capital Management first reported a position in NervGen Pharma in Q1 2026 and has held it in 3 quarters since.
  • Traynor Capital Management's NervGen Pharma position peaked at $95.1K in Q1 2026.
  • 68 funds tracked by Wall St. Rank held NervGen Pharma as of Q3 2026.

Based on Traynor Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.